SA
ENVB logo
Enveric Biosciences, Inc.(ENVB)
Closing price · checked 8:22 PM ETAbout this dataData status
$1.35▼-0.06 (-4.26%)
Extended:$1.25-0.10 (-7.41%)· 8:22 PM ET

S&P 500, Nasdaq, Russell 2000 below the 200-day average · VIX 35.9 · very high volatility

Overview →
Next report

Apr 1 2027in 131 days

EPS estimate

($1260.00)

Revenue estimate

—

EPS beats

4 of last 9

Earnings SurpriseEPS, actual vs estimateLatest +101.5%

How far reported EPS beat (+) or missed (−) the analyst estimate that stood when each report landed.

2024: -16852.9%2024: -14158.4%2024: -8081.8%2024: -8207.7%2025: -1580.0%2025: 79.7%2025: 81.5%2025: 82.8%2026: 101.5%-16852.9%-8081.8%-1580.0%81.5%101.5%
Mar 26 2024Mar 27 2026
ReportedEPS estEPS actualSurpriseRevenue estRevenue actualSurprise
Nov 13 2026—($0.57)————
Aug 14 2026—($0.76)————
May 15 2026—($1.08)————
Mar 27 2026($55.80)$0.85+101.5%———
Nov 14 2025($63.00)($10.81)+82.8%———
Aug 11 2025($63.00)($11.64)+81.5%———
May 13 2025($72.00)($14.64)+79.7%———
Mar 31 2025($3.45)($57.96)-1580.0%———
Nov 14 2024($0.52)($43.20)-8207.7%———
Aug 12 2024($0.55)($45.00)-8081.8%———
May 15 2024($0.77)($109.79)-14158.4%———
Mar 26 2024($1.55)($262.77)-16852.9%———

Earnings & Revenue Estimates

Last reported Earnings history refreshes daily; a new report appears within about 2 daysAbout this data

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.